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Abstract
Purpose of Review Among the non-tuberculousmycobacteria (NTM),Mycobacterium avium complex (MAC) is the leading cause of
pulmonary disease in humans. Innate and acquired immunodeficiencies have been associated with an increased host susceptibility to
NTM infections. The underlying mechanisms predisposing humans and dogs to MAC infections are being elucidated.
Recent Findings Although MAC infection is infrequently diagnosed in dogs, a strong breed predisposition particularly for
Miniature Schnauzer and Basset Hound dogs is evident. A recessively inherited defect of the adaptor protein CARD9 has
recently been documented to be responsible for the increased susceptibility to MAC in the Miniature Schnauzer breed.
Summary Given the zoonotic potential of a MAC-infected dog particularly to immunocompromised human patients, diseased
dogs pose a public health risk.While not a reportable disease, treatment of systemicmycobacteriosis is generally not effective and
discouraged in dogs. The collaborative efforts by microbiologists, veterinary clinicians, dog breeders, primary care physicians,
and infectious disease specialists applying the One Health approach are therefore crucial for the best management and prevention
of MAC infection.
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Introduction
Mycobacterial infections are caused by bacteria that belong to the
family Mycobacteriaceae, order Actinomycetales. The genus
Mycobacterium recently underwent important taxonomic change
proposals, and the redistribution of 150 Mycobacterium species
into five new genera has become a controversial issue among
microbiologists, clinicians, and researchers [1, 2•]. Besides the
emended genusMycobacterium, the four newly proposed genera
Mycobacteroides, Mycolicibacter, Mycolicibacterium, and
Mycolicibacillus are still debated regarding the phylogeny and
taxonomy of large bacterial clades. On one hand, the necessity of
an up-to-date core genome sequence-based phylogeny and tax-
onomy of a large heterogeneous group, such as the genus
Mycobacterium, contributes to a more precise understanding of
bacterial rise and evolution [1]. On the other hand, such drastic
changes have led to confusions and potentially impede the ex-
change of information between researchers, microbiologists, and
clinicians and, thereby, to patients and pet owners [2•, 3].
Moreover, some of the newly proposed genera or families com-
prise pathogens causing various notifiable diseases worldwide;
therefore, misinterpretation of microbiology test results may oc-
cur. Few species mentioned, hereafter, have been recently pub-
lished according to the newly proposed nomenclature, e.g.,
Mycolicibacterium smegmatis for Mycobacterium smegmatis.
Therefore, for the sake of clarity, mycobacterial species in the
present manuscript will be preceded by “M.” referring to
Mycobacterium, regardless of the recently proposed
nomenclature.
Although extremely heterogeneous in their host affinity
and pathogenic potential, mycobacteria share important mor-
phological similarities. Mycobacteria are aerobic bacteria,
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non-spore-forming, and non-motile. Because of the high con-
centration of mycolic acid in their cell walls, mycobacteria are
difficult to stain with common techniques, such as the Gram
stain. However, once mycobacteria are heated in the presence
of carbol-fuchsin, this stain can penetrate their lipid-rich cell
wall. And while other non-acid-fast bacteria are commonly
decolorized by acid alcohol, mycobacteria are able to retain
the Ziehl-Neelsen dye [4]. For this reason, mycobacteria are
also commonly called acid-fast bacteria, which is, however,
not unique to this genus. Other medical-relevant genera be-
longing to the Actinomycetales, such as Nocardia and
Rhodococcus, are also acid-fast and could be erroneously
misidentified as mycobacteria by Ziehl-Neelsen stain.
The recent enormous advances in molecular genetic tech-
niques allowed readily the sequencing of single or multiple
housekeeping genes followed by whole genome sequencing
of any bacteria. Microbial isolates can nowadays be identified
with the highest accuracy expediently and relatively inexpen-
sively which led to the definitive description and partial re-
classification of a myriad of new species and genera as well as
precision medicine. Alone during the past decade, more than
50 new species of mycobacteria were published [5].
Although whole genome sequencing of bacteria is being
progressively implemented in diagnostic laboratories, it is not
(yet) feasible for daily routine diagnostic purposes. Currently,
reverse hybridization-based line-probe commercial kit assays
are commonly used for mycobacterial identification of clinical
isolates. In addition, matrix-assisted laser desorption
ionization–time of flight mass spectrometry (MALDI-TOF
MS) has proven to be a rapid and accurate tool in the diagnos-
tic workflow of larger laboratories [6, 7]. Nevertheless, accu-
racy of the MALDI-TOF MS-based species identification re-
mains inferior to genome sequencing [5].
Mycobacterial diseases are clinicopathologically divided
into two main groups: tuberculosis and mycobacteriosis.
Tuberculosis (TB) in humans and different animal species
is caused by the members of the Mycobacterium tuberculosis
complex (MTBC), which are obligate pathogens showing
marked host predilections. The MTBC includes currently the
human-adapted speciesM. tuberculosis andM. africanum; the
animal-adapted M. bovis , M. caprae , M. microti ,
M. pinnipedii, M. orygis, the “dassie bacillus”; and the more
recently discoveredM. mungi, the “chimpanzee bacillus”, and
M. suricattae [8]. In addition, M. canettii is also considered a
member of the MTBC based on nucleotide identity, albeit
opportunistic infections in humans [8]. The members of the
MTBC are believed to be host-adapted and, with the excep-
tion of M. canettii which has a putative environmental reser-
voir, they can be found in contaminated environments. Dogs
infected with M. tuberculosis, M. bovis, and M. microti have
been rarely documented worldwide [9–11]. Therefore, dogs
are considered a spillover host for MTBC pathogens, meaning
that there is no maintenance of the pathogen within the canine
population without continued exposure to a primary host and
reservoir [12].
The modality of infection with MTBC members depends
on the specific pathogen (M. tuberculosis, M. bovis,
M. microti) and the geographical and socio-economic envi-
ronment of dogs. The infection with the human-adapted
M. tuberculosis is spread almost exclusively by airborne trans-
mission, and the lungs are its primary target. The
mycobacteria can disseminate, resulting in various other clin-
ical manifestations depending on the affected organ. To the
contrary,M. bovis andM. microti are believed to be transmit-
ted to dogs via contaminated animal products. Independently
from the infecting species, canine TB is characterized by a
long incubation period (months to years) resulting in asymp-
tomatic carriers and chronic slowly progressive disease that
can be often detected solely by indirect diagnostic test
methods.
In most countries, contrary to human and livestock species,
collection and submission of samples for mycobacterial test-
ing from a dog when suspecting TB is not mandatory, but
rather initiated based upon good clinical judgment by a clini-
cian and dog owner. Moreover, there are no regulations on
managing dogs after documentation of MTBC, but due to the
high zoonotic risk, euthanasia is generally recommended.
Furthermore, the prolonged administration of antituberculosis
agents can be highly toxic to dogs.
Mycobacteriosis is caused by opportunistic pathogenic
non-tuberculous mycobacteria (NTM). The NTM are ubiqui-
tous, e.g., in soil and water, and healthy humans and animals
are considered fairly resistant to mycobacteriosis. Among
NTM, two species are recognized as true pathogens for
humans, namely M. marinum and M. ulcerans [13].
Nevertheless, more than 60 species of NTM are known to be
opportunistic pathogenic to humans and other mammals, and
infections with these emerging pathogens are now more com-
mon than tuberculosis in industrialized countries [5, 14, 15].
Geographical differences concerning the prevalence of differ-
ent NTM have been described in veterinary and human med-
icine, e.g., higher prevalence of feline leprosy caused by a
number of mycobacteria, namely, M. lepraemurium,
M. visibile, and novel mycobacterial species such as
Mycobacterium sp. Tarwin, in cats is seen in temperate mar-
itime climates [16]. Similarly, the buruli ulcer, a chronic skin
disease in humans caused by M. ulcerans, occurs mostly in
tropical and subtropical regions [17]. Themost commonNTM
species encountered in humans with lung infections are mem-
bers of the Mycobacterium avium complex (MAC),
M. abscessus, and M. kansasii depending on geographical
regions [18]. Numerous NTM have been reported in dogs
causing a variety of clinical manifestations, including skin,
respiratory, gastrointestinal, and disseminated disease.
To date, the virulence of specific mycobacterial species and
their strains for a particular host and whether a transmission
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from domestic or wild animals to humans and vice versa can
occur remain largely unknown. Moreover, the reason why
ubiquitous mycobacteria are able to cause serious life-
threatening illness to some individuals while being innocuous
to other individuals of the same species is now being elucidated.
In human and veterinary medicine, underlying hereditary and
acquired immunodeficiency disorders have recently been dis-
covered to cause predispositions specifically tomycobacteriosis
and may guide selection of treatment including triple drug ther-
apy. In dogs, infections due to NTM are sporadically reported
worldwide, but the exact source of the mycobacteria remains in
most cases unknown. Epidemiological data concerning NTM
infections of dogs are missing. Moreover, time-consuming and
laborious detection methods and a low disease awareness could
be responsible for a potentially large number of undiagnosed
cases. Indeed some dogs in Miniature Schnauzer breed have a
common genetic predisposition to NTM which has been docu-
mented from clinicopathological signs to the molecular genetic
defect. A rapid genotyping approach currently permits precise
detection of diseased dogs and asymptomatic carriers, facilitat-
ing specific management and prevention in future generations.
Mycobacterium tuberculosis
Mycobacterium tuberculosis is the primary cause of TB in
humans worldwide, with the exception of few specific geo-
graphical regions (e.g., M. africanum in West Africa), and can
also occur in dogs after prolonged close contact with TB pa-
tients [19, 20].Mycobacterium tuberculosis can be experimen-
tally transmitted by close contact between animals, and, conse-
quently, infected dogs could act as reservoir for human infec-
tions [21]. Pulmonary, cutaneous, and disseminated disease
manifestations have been reported in dogs [11, 22–25]. In most
cases, the infection develops with granulomatous inflammation
localized mainly to the lungs, skin, kidneys, bone marrow, and/
or digestive system and associated lymph nodes [21].
Mycobacterium bovis
Mycobacterium bovis is the pathogenic agent causing TBwith
the broadest known host spectrum. Infection chains in numer-
ous domestic and wild mammal and the resulting transmis-
sions to humans have recently led to the term “zoonotic TB”
by the World Health Organization (WHO) [26]. Furthermore,
the number of M. bovis, and to a lesser extent by the closely
related M. caprae, infections in humans might well be
underestimated because of a lack of diagnostic surveillance
programs [26]. Nevertheless, M. bovis infections are rare in
dogs and, as in humans, mostly associated with consumption
of raw milk or contaminated byproducts from affected rumi-
nants [27–29]. Clinical findings of infected dogs vary from
respiratory signs and cutaneous lesions to gastrointestinal
signs accompanied by fever, inappetence, and weight loss.
Gray wolves (Canis lupus), ancestors of the domestic dog,
are susceptible to natural infections with M. bovis and
M. caprae [30, 31] and may be infected by their preys such
as domestic and wild ruminants. Interestingly, their TB seems
to be mild and self-limiting. Since diseased wild ungulates are
an easy prey of wolves, they may play a role in controlling TB
in wild ruminant populations [31]. Domestic dogs may be
more prone to tuberculosis because of their restricted genetic
pool and associated increased inbreeding practices.
Non-tuberculous Mycobacteria
Non-tuberculous mycobacteria (NTM) are commonly divided
into rapidly growing mycobacteria which usually grow in
subculture within 1 week and those that require longer incu-
bation to form visible colonies and are termed slowly growing
mycobacteria such as the members of the MAC [15]. In dogs,
a large variety of rapid- and slow-growing mycobacteria can
cause mycobacterial granulomas of the cutis and subcutis, and
the resulting lesions are clinically mostly indistinguishable
[32••].
TheMycobacterium sp. causing canine leproid granulomas
has yet to be isolated in culture and sequenced. Canine leproid
granuloma is a nodular dermatosis affecting the cutis and sub-
cutis of the dog, usually located on the head, especially on the
dorsal fold of the ears. Although the geographical distribution
of the disease is probably wider, dogs with leprosy have been
mostly described from Australia, where it is the predominant
mycobacterial disease of dogs, Brazil and the USA, particu-
larly in the Central Valley of California [32••, 33, 34].
Mycobacterium ulcerans, the environmental pathogen re-
sponsible for the Buruli ulcer disease, can infect both humans
and animals and remains a major public health problem [17,
35]. Although the ecology and transmission of this pathogen
remain mostly unexplained, recent research and phylogenetic
analyses suggest a common environmental source of contam-
ination for humans and animals, including domestic dogs [35].
Painless nodules, papules, necrotic ulcers, plaques, and/or
edema of the cutis and subcutis are common clinical features
of this infectious disease in humans and dogs [36]. In addition,
similar chronic non-healing cutaneous and subcutaneous le-
sions have been described in dogs with rapidly growing (e.g.,
M. smegmatis [37],M. goodii [37, 38],M. fortuitum [37, 39],
and M. chelonae-abscessus [40]) and slowly growing
mycobacteria, (e.g., MAC, M. nebraskense [41]).
Apart from cutaneous and subcutaneous infections and the
subsequently discussed MAC infections, clinical manifesta-
tions due to NTM infections in dogs have been rarely report-
ed, e.g., pulmonary disease due toM. fortuitum [42–44], mas-
titis and persistent pleural effusion caused byM. kansasii [45,
46], or disseminated disease characterized by lameness and
ataxia with M. smegmatis [47] and M. genavense [48].
69Curr Clin Micro Rpt (2020) 7:67–80
Mycobacterium avium Complex
The MAC, encompasses a heterogeneous group of slow-
growing NTM that are opportunistic pathogenic for humans
and animals. Historically, the complex consisted of two species:
M. avium and M. intracellulare. This classification was based
upon the pathogenity to birds, being M. avium pathogenic and
M. intracellulare experimentally avirulent to fowls [49••]. With
the major diagnostic improvements and heightened awareness
among clinicians, new MAC species were described including
M. arosiense, M. bouchedurhonense, M. chimaera,
M. colombiense , M. ituriense , M. lepraemurium ,
M. marseillense, M. paraintracellulare, M. scrofulaceum,
M. timonense, M. vulneris, and M. yongonense [49••]. The fre-
quency of isolating MAC members varies geographically with
M. intracellulare seen frequently in human patients in Australia
and South Africa and M. avium predominating in Europe and
the Americas [50]. In immunocompromised humans, such as
HIV patients or transplant recipients, MAC is the leading cause
of pulmonary and disseminated mycobacteriosis [15, 49••].
However, healthy humans and animals are considered to be
rather resistant to develop MAC-related mycobacteriosis.
The speciesMycobacterium avium is currently divided into
four subspecies including avium (MAA), silvaticum (MAS),
hominissuis (MAH), and paratuberculosis (MAP) based on
phenotypic peculiarities such as mycobactin J dependency
(MAP and MAS) or specific genetic markers that will be fur-
ther discussed below [49••, 51••]. It has to be mentioned that,
because of financial or technical constraints, only specialized
laboratories can accurately distinguish between MAA, MAH,
or novel MAC members, such as M. colombiense and
M. chimaera. As indicated by its name, the subspecies MAH
is frequently recovered from humans and swine. In addition,
this ubiquitous environmental saprophyte has a broad host
range, and cases of disseminated MAH infection have been
described in other mammals, including dogs, cats, cattle,
goats, domestic rabbits, free-ranging red deer, African ele-
phants, and horses [52–59].
Remarkable genetic heterogeneity among MAH strains has
been elucidated with specific molecular markers including in-
ternal transcribed spacer (e.g., sequevars Mav-A and Mav-B),
insertion sequences (ISMav6), or multispacer sequence typing
(e.g., MST22) [60•, 61•, 62]. Consequently, an association
between certain genotypes and increased virulence, ability of
long-term persistence and biofilm formation, or host-species
predilection is evident.
Assuming that MAP is an obligate pathogen of ruminants
and MAA/MAS are obligate pathogens of birds, MAH has
been proposed to be the only true environmental subspecies
ofM. avium [51••]. MAP is an obligate intracellular pathogen,
especially in ruminant species and is the etiological agent of
paratuberculosis, a contagious disease listed by the World
Organisation for Animal Health and also known as Johne’s
disease. This chronic progressive intestinal disease has also
been reported in horses, pigs, deer, alpaca, llama, rabbits,
free-ranging carnivores, and dogs [52, 63, 64]. The granulo-
matous gastroenteritis is causing diarrhea, malabsorption, de-
creased milk production, and wasting [52, 64, 65]. The MAA
andM. genavense are considered a major bird pathogen, caus-
ing avian mycobacteriosis but only occasionally infections
and disease in other animals and humans [51••]. In contrast,
MAH has only rarely been isolated from tuberculous lesions
in birds [66]. Therefore, the common belief that contaminated
poultry carcasses or excrements/droppings are a major source
of MAC infections for dogs should be dismissed.
In most published canine case reports, the involved
M. avium subspecies was not identified [67–76]. However,
according to recent studies and unpublished data by authors,
MAH appears to be the predominant pathogenic subspecies
[77•, 78•, 79•, 80•]. Occasionally, mycobacteriosis due to
MAP [64] or MAA [81] has been reported in dogs. To date,
there are over 43 published cases reporting MAC-related
mycobacteriosis in dogs (Table 1); however, there are many
more unreported cases particularly in the Miniature Schnauzer
and Basset hound breeds. Absence of epidemiological data for
a non-notifiable disease, negligible impact of additional case
reports, and misdiagnoses are some of the reasons for this
underreporting.
As MAH is ubiquitous and dogs are likely confronted with
this opportunistic pathogen from an early stage of their life
almost daily, it can be stated that the number of clinical infec-
tions caused in dogs and humans is extremely low. However,
as it is for humans, immunocompromised dogs can develop
systemic and life-threatening mycobacteriosis due to MAC
infection. And indeed even among the published case reports
(43 cases), a breed predilection to MAC infection is evident
for Miniature Schnauzers (16 cases) and Basset Hounds (10
cases). Because over a half (60%) of all published cases are in
breeds with a known genetic predisposition, the summary of
these cases is heavily influenced by those with a clear breed
predisposition. Among the case reports, most affected dogs
were young, with the highest risk of developing signs within
the first 3 years of age and only rarely in dogs older than
5 years. Weight loss, lethargy, and inappetence were the
predominating signs, followed by lymphadenopathy, spleno-
megaly, and gastrointestinal signs. Other less common clinical
signs included spinal pain, paresis, lameness, subcutaneous
swellings, and diffuse alopecia. Extensive granulomatous in-
vasion was found in various examined organs including the
small and large intestine, spleen, liver, lungs, bone marrow,
and various lymph nodes (inguinal, mediastinal, mesenteric,
prescapular, submandibular) in most dogs.
While there are many genetic predispositions to infections
in humans and animals, few are restricted to very specific
organisms like mycobacteria. Hereditary immunodeficiencies
in human patients with mycobacteriosis have been associated
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with variants in both subunits of the IFN-γ receptor, beta-1
chain of the interleukin-12 receptor, or the signal transducer
and activator of transcription 1 (STAT1), which plays a
crucial role in controlling intracellular responses to bacteria
and viruses [82–84]. However, acquired immunodeficiencies
are far more common than hereditary predisposition.
Furthermore, the causative nature of the specific gene defects
has been less well-defined. Recently, a single variant in the
caspase recruitment domain-containing protein 9 (CARD9)
gene has been documented in Miniature Schnauzer dogs
[85] (manuscript in preparation UG).
The CARD9molecule is amulti-functional signaling protein
and is essential in autonomous innate host defense against a
variety of fungal species, including Candida albicans,
Aspergillus fumigatus, or Cryptococcus neoformans and intra-
cellular bacterial pathogens such as Listeria monocytogenes
and M. tuberculosis [86, 87]. The CARD9 signaling pathway
plays a pivotal role in autonomous innate host defense against
M. tuberculosis [86]. Granulocytes from CARD9-deficient
mice failed to produce IL-10 after infection and were not able
to control bacterial replication, whereas T cell response ap-
peared unaffected [86]. To date, similar effects of CARD9 var-
iants in humans have not been observed in association with
mycobacterial infections. Genotyping showed that Miniature
Schnauzer homozygous for the CARD9 variant gene always
developed systemic mycobacteriosis caused by M. avium.
This is an autosomal recessively inherited trait, and a common
ancestor of diseased dogs has been found dating back to the late
1980s. While over 100 Miniature Schnauzers have been found
to have developed mycobacteriosis over the past three decades,
a precision medicine approach including screening for this var-
iant offers not only a precise diagnosis but also detection for
carriers to avoid the production of any predisposed offspring in
the breed. Mycobacterium avium is not the only opportunistic
NTM that is present in the environment; and the reason why
MAH infections are predominating remains unknown and
might suggest a host-MAH-specific interaction.
The other breed with a genetic predisposition to MAC-
associated mycobacteriosis is the Basset Hound. This unique
susceptibility presents similarly but seems to be less common
than in Miniature Schnauzers, and the underlying cause still
needs to be elucidated. While tuberculosis due to MTBC infec-
tions in the gray wolves has been described, mycobacteriosis
due to NTM has so far not been reported, further supporting the
innate resistance of canidae against MAC except those with
hereditary or acquired immunodeficiencies. Inbreeding does
not raise the risk of new allele variants, but it can increase
homozygosity of deleterious autosomal recessive traits as seen
with the CARD9 variant in Miniature Schnauzers [88]. The
engagement and collaboration of researchers, veterinary clini-
cians, and dog breeders are therefore crucial for the further
prevention of this fatal infection and to understand the under-
lying mechanisms of MAH invasion.
Diagnosis and Prevention
Ante-mortem diagnosis of a mycobacterial infection can be
challenging, especially in cases where only internal organs
are affected. Tuberculin skin tests (TST) for diagnosis of tu-
berculosis have been applied in dogs but has been shown to be
of unreliable clinical utility and should not be used [20, 21,
89]. Currently, there are no validated commercial in vitro as-
says such as serological or whole-blood tests that can measure
the immune reactivity of infected or sensitized dogs specifi-
cally against mycobacteria. With the interferon-gamma
(IFN-γ) release assays (IGRA), the amount of released
IFN-γ after antigen-specific stimulation can be quantified.
The IGRA can be performed using purified protein derivative
(PPD) from MTBC (e.g., M. tuberculosis or M. bovis), and
avian PPD (M. avium) as antigens, or more specific stimulants
such as early secretory antigenic target 6 kDa (ESAT-6) and
culture filtrate protein 10 kDa (CFP-10). Commercial collec-
tion tubes coated on the inner surface with the necessary stim-
ulants enabling immediate exposure of viable lymphocytes to
specific mycobacterial antigens are now available [90].
Different IGRAs have been successfully used in domestic
dogs and other canidae to detect immunological sensitization
to MTBC [20, 90, 91]. Similarly, IGRAs for the early diag-
nosis of Johne’s disease caused by MAP showed promising
results in farm ruminants [65, 92, 93]. The ubiquitous nature
of MAH impedes the implementation of an IGRA assay for
canine M. avium detection, as it may merely reflect exposure
to MAH and would not be informative about the current in-
fection and disease status of the tested dogs.
Fine needle aspiration or biopsy specimens from cutaneous
lesions and enlarged lymph nodes can readily be obtained in
veterinary practice. In the presence of acid-fast bacteria after
Ziehl-Neelsen staining and/or histopathological finding such
as caseating granulomatous lesions, a mycobacterial infection
can be suspected. However, the only definitive means to cor-
rectly identify the observed mycobacteria is by cultures or
molecular methods. Due to the potential zoonotic risk and in
cases where treatment is appropriate, it is important to identify
the involved Mycobacterium sp. and perform antimicrobial
susceptibility testing after mycobacterial isolation. However,
mycobacterial cultures should only be performed by
established specialized laboratories.
Techniques to identify rapid- and slow-growing
mycobacteria depend on the laboratory infrastructure, equip-
ment, expertise, and specimen to be tested. Traditional bio-
chemical tests, specific reverse hybridization–based line-
probe commercial kit assays, sequence analysis of selected
housekeeping genes, andMALDI-TOFMS are valid methods
currently used alone or in combination. Molecular genetic
techniques, in particular specific gene or whole genome se-
quencing, allow for a better discrimination than traditional
culture and biochemical methods, resulting in the recent
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description of a myriad of new species. The 16S rRNA gene,
coding for a component of the 30S small subunit of the pro-
karyotic ribosome, is the most common gene used for identi-
fication and phylogeny of bacteria [94]. Sequence analysis of
the 16S rRNA gene has become a cornerstone of mycobacte-
rial classification and taxonomy because of its discriminatory
power and the availability of comprehensive freely accessible
databases. However, because of the high genetic similarity of
certain closely related mycobacteria, 16S rRNA gene analysis
does not provide the necessary resolution capacity. For in-
stance, the four subspecies ofMycobacterium avium are char-
acterized by identical 16S rRNA gene sequences.
Beside the fundamental phenotypic features, such as
mycobactin J dependency ofMAP andMAS, additionalmarkers
for the differentiation of MAC species andM. avium subspecies
have been described and should be applied. These include inser-
tion sequences (IS), e.g., IS901 present in MAA and MAS,
IS900 found in MAP and ISMav6, which is a genetic variant
of the original bird-type IS901, and a marker associated with
virulent MAH strains [49••]. Another discriminating gene for
M. avium subspecies is hsp65, particularly its 3′-region, which
has been shown to contain subspecies-specific signatures [95].
When specifically analyzed, dogs with MAC mycobacteriosis
are predominantly infected with MAH.
In Miniature Schnauzer dogs, the increased susceptibility to
MAC infection and diagnosis of mycobacteriosis can be simply
predicted even prior to exhibiting disease by showing homozy-
gosity for the breed-specific CARD9 variant by PCR testing. In
this regard, the proactive screening of Miniature Schnauzers
used in breeding programs is reducing the number of MAC
susceptible dogs carrying this deleterious variant from the
breed. No DNA test is currently available for testing the genetic
susceptibility to MAC infections in Basset Hounds [85].
Management
Due to the high zoonotic risk of MTBC members, dogs diag-
nosed with tuberculosis should not be treated and humanely
euthanized. Contact to dogs with TB should be restricted and
exposed people, particularly those with immunodeficiency
and immunosuppression, should be advised to contact their
primary care physician and/or infectious disease specialist to
undergo appropriate diagnostic investigations and potentially
treatment. Although interspecies transmission of NTM has not
been unequivocally described, the zoonotic potential of affect-
ed animals with any Mycobacterium sp. should not be
underestimated. The minimal infective dose of most NTM
species for human beings is yet to be determined, and infected
dogs expose their potentially immunocompromised owners
and other people to a far higher infection pressure even before
they are showing obvious clinical signs. Among the members
of the MAC, onlyM. vulneris has been specifically associated
with a possible transmission between dogs and humans, as
M. vulneris was cultured from an infected dog bite wound of
a 42-year-old woman [96].
Because of the potential zoonotic risk and increasing inter-
actions between human and companion animals, immunolog-
ically compromised people who are in close contact with
NTM-infected dogs should be referred to their primary care
physicians. According to the available literature, diagnostics
and therapy of NTM infections depend on the mycobacterial
(sub-) species, localized or systemic disease manifestation, as
well as the host defense status. Any treatment attempts should
be discouraged in breeds with an immunodeficiency.
Localized or disseminated cutaneous infections such as
pyogranulomatous dermatitis and panniculitis with or without
systemic clinical signs seem to have a favorable prognosis
after prolonged antimicrobial therapy in dogs other than
Miniature Schnauzers or Basset Hounds [79•, 97, 98].
Because isolation and susceptibility testing of mycobacteria
is usually protracted for slowly growing mycobacteria, initial
empiric antimycobacterial therapy is often necessary to im-
pede the spread to adjacent tissue compartments [99]. The
combination of antimycobacterial agents effective against
slowly growing NTM, such as rifampicin and clarithromycin,
combined with newer generation fluoroquinolones, e.g.,
moxifloxacin or pradofloxacin, has been used in isolated cases
[32••, 100]. Doxycycline, macrolide, or fluoroquinolone as
monotherapy is a common practice in veterinary medicine
but may well not be effective even in immunocompetent dogs.
The experience from the literature shows that once the dis-
ease is disseminated, MAC mycobacteriosis is progressive
and affected animals die or have to be euthanized regardless
of any treatment attempts.
Infection Sources for Mycobacterium avium
Because of the ubiquitous nature of MAH in soil and water,
different possible transmission routes, the broad host range, un-
specific clinical signs, and long incubation period (weeks to
months) of the disease, MAC infections in dogs represent epide-
miological challenges (Fig. 1). The source and time of infection
remain generally unknown and, thus, retrospective contact trac-
ing is impractical. Whether infected animals, especially pets with
close contact to their owners, play a role in the epidemiology of
humanmycobacteriosis caused byM. avium is still to be defined.
Noteworthy, only a low degree of homology between MAH
isolates from Japanese human patients and local pigs was ob-
served, whereas isolates fromEuropean human patients and from
pigs in Japan and Europe were highly similar [53, 61•, 62•, 101,
102]. However, the source and time ofMAC infection remains in
most human patients and dogs unknown due to the long incuba-
tion period until overt disease occurs. Interregional or even inter-
national travel is commonly done for show dogs, pet purchases,
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breeding, and even for shelters. Whether MAC-infected dogs,
especially pets with close contact to (immunocompromised)
humans, play a role in infecting people remains to be determined.
A commonly discussed infection source for humans is aero-
solized water particles such as those generated from shower-
heads. M. avium has been identified from biofilms of shower-
heads in the USA using a culture-independent approach [103],
and bathroom’s colonization with MAC organisms originating
from infected patients has been hypothesized in Japan [104]. The
possibility thatMAC transfers from the patient to their bathroom,
and that tap water may not be the source of infection, has been
corroborated by studies from Japan, showing that NTM were
rare or not detectable in bathroom samples from control patients
and kitchen tap water [104, 105]. In Germany, MAHwas recov-
ered in dust and soil by culturing indoor and outdoor samples.
Interestingly, MAH was significantly more often isolated from
locationswith close human contact such as indoor home dust and
biofilms from sanitation facilities compared with countryside
samples containing water, biofilm, and soil [106]. The MAC
member M. chimaera was found in heater-cooler devices used
in cardiac surgery leading to worldwide invasive nosocomial
infections in humans [107, 108].
Free-living amoebae are common unicellular eukaryotes liv-
ing in soil, brackish water, and potable water distribution sys-
tems [109] including hospital water systems [110]. They feed
























Fig. 1 Infection sources of Mycobacterium avium subsp. hominissuis
(MAH) for dogs and common anatomical locations of mycobacteriosis;
note frequently disseminated manifestation. Mycobacterium avium
subsp. hominissuis is widely distributed in soil, ground- and tap water.
While various mammals belong to the host range ofMAH and potentially
spread the mycobacteria into their living environment, birds are not likely
to be a source of infection. Moreover, free-living organisms such as
amoebae harbor MAH and may act as vehicles for the mycobacteria.
Yellow stars represent the most commonly enlarged lymph nodes
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and other microorganisms. However, many mycobacteria are
known to be resistant against their phagocytosis and are able to
reside unharmed and evenmultiply within the amoebal exocyst
[111–114]. Thereby, mycobacteria can persist under adverse
environmental conditions and against disinfectants, e.g., chlo-
rine used for reduction of water-borne pathogens [115, 116].
Therefore, amoebal cysts are probable vehicles for opportunis-
tic pathogens such as MAC, which can rapidly exit the cyst
once ingested by mammals or further colonize the patient’s
environment. These findings suggest marked geographic dif-
ferences, possibly influences by socio-economic aspects such
as water supplies systems, local diets, and cooking habits.
Conclusions
Mycobacteriosis caused by MAC in an emerging disease in
humans and dogs. While acquired immunodeficiencies prevail
in human patients, a genetic predisposition to MAC in two
breeds is responsible for most reported cases in dogs.
Synergistic efforts from microbiologists, clinicians, infectious
disease specialists, and breeders applying the One Health ap-
proach are necessary to improve our understanding of canine
mycobacteriosis and assure animal and human health. Dogs with
CARD9deficiencymay prove to be an appropriate animalmodel
to study the host-microbe interactions and efficacy of treatments.
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